Chao Wang

Dr. Chao Wang


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2022 in Frontiers in Neuroscience
Verified
Journal Article
Open access
LHLing Hu
Ling Hu
SYSiyu Yang
Siyu Yang
BJBo Jin
Bo Jin
CWChao Wang
Chao Wang
Traumatic brain injury (TBI) is a common source of morbidity and mortality among civilians and military personnel. Initial routine neuroimaging plays an essential role in rapidly assessing intracranial injury that may require intervention. However, in the context of TBI, limitations of routine neuroimaging include poor visualization of more subtle changes of brain parenchymal after injury, poor prognostic ability and inability to analyze cerebral perfusion, metabolite and mechanical properties. With the development of modern neuroimaging techniques, advanced neuroimaging techniques have greatly boosted the studies in the diagnosis, prognostication, and eventually impacting treatment of TBI. Advances in neuroimaging techniques have shown potential, including (1) Ultrasound (US) based techniques (contrast-enhanced US, intravascular US, and US elastography), (2) Magnetic resonance imaging (MRI) based techniques (diffusion tensor imaging, magnetic resonance spectroscopy, perfusion weighted imaging, magnetic resonance elastography and functional MRI), and (3) molecular imaging based techniques (positron emission tomography and single photon emission computed tomography). Therefore, in this review, we aim to summarize the role of these advanced neuroimaging techniques in the evaluation and management of TBI. This review is the first to combine the role of the US, MRI and molecular imaging based techniques in TBI. Advanced neuroimaging techniques have great potential; still, there is much to improve. With more clinical validation and larger studies, these techniques will be likely applied for routine clinical use from the initial research.

1 January 2022 in Therapeutic Advances in Neurological Disorders
Verified
Journal Article
Open access
CWChao Wang
Chao Wang
CZCheng Zhou
Cheng Zhou
TGTao Guo
Tao Guo
PHPeiyu Huang
Peiyu Huang
XXXiaojun Xu
Xiaojun Xu
MZMinming Zhang
Minming Zhang
Background: Mounting evidence has revealed an inverse association between cigarette smoking and the risk of Parkinson’s disease (PD). Meanwhile, cigarette smoking has been found to be associated with cognitive impairment in PD patients. However, the neural mechanisms of the association between cigarette smoking and PD are not fully understood. Objective: The aim of this study is to explore the neural mechanisms of the association between cigarette smoking and PD. Methods: A total of 129 PD patients and 69 controls were recruited from the Parkinson’s Progression Markers Initiative (PPMI) cohort, including 39 PD patients with regular smoking history (PD-S), 90 PD patients without regular smoking history (PD-NS), 26 healthy controls with regular smoking history (HC-S), and 43 healthy controls without regular smoking history (HC-NS). Striatal dopamine transporter (DAT) binding and gray matter (GM) volume of the whole brain were compared among the four groups. Results: PD patients showed significantly reduced striatal DAT binding compared with healthy controls, and HC-S showed significantly reduced striatal DAT binding compared with HC-NS. Moreover, smoking and PD showed a significant interaction effect in the left medial prefrontal cortex (mPFC). PD-S showed reduced GM volume in the left mPFC compared with PD-NS. Conclusion: The degeneration of dopaminergic neurons in PD results in a substantial reduction of the DAT and dopamine levels. Nicotine may act as a stimulant to inhibit the action of striatal DAT, increasing dopamine levels in the synaptic gap. The inverse alteration of dopamine levels between PD and nicotine addiction may be the reason for the inverse association between smoking and the risk of PD. In addition, the mPFC atrophy in PD-S may be associated with cognitive impairment.

4 May 2022 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
TQTiantian Qiu
Tiantian Qiu
FXFei Xie
Fei Xie
QZQingze Zeng
Qingze Zeng
ZSZhujing Shen
Zhujing Shen
GDGuijin Du
Guijin Du
FNFor The Alzheimer'S Disease Neuroimaging
For The Alzheimer'S Disease Neuroimaging
Aims: Cigarette smoking is a modifiable risk factor for Alzheimer's disease (AD), and controlling risk factors may curb the progression of AD. However, the underlying neural mechanisms of the effects of smoking on cognition remain largely unclear. Therefore, we aimed to explore the interaction effects of smoking × cognitive status on cortico‐striatal circuits, which play a crucial role in addiction and cognition, in individuals without dementia.Methods: We enrolled 304 cognitively normal (CN) non‐smokers, 44 CN smokers, 130 mild cognitive impairment (MCI) non‐smokers, and 33 MCI smokers. The mixed‐effect analysis was performed to explore the interaction effects between smoking and cognitive status (CN vs. MCI) based on functional connectivity (FC) of the striatal subregions (caudate, putamen, and nucleus accumbens [NAc]).Results: The significant interaction effects of smoking × cognitive status on FC of the striatal subregions were detected in the left inferior parietal lobule (IPL), bilateral cuneus, and bilateral anterior cingulate cortex (ACC). Specifically, increased FC of right caudate to left IPL was found in CN smokers compared with non‐smokers. The MCI smokers showed decreased FC of right caudate to left IPL and of right putamen to bilateral cuneus and increased FC of bilateral NAc to bilateral ACC compared with CN smokers and MCI non‐smokers. Furthermore, a positive correlation between FC of the NAc to ACC with language and memory was detected in MCI smokers.Conclusions: Cigarette smoking could affect the function of cortico‐striatal circuits in patients with MCI. Our findings suggest that quitting smoking in the prodromal stage of AD may have the potential to prevent disease progression.

6 January 2023 in Medicine
Verified
Journal Article
Open access
CWChao Wang
Chao Wang
HXHuanhuan Xie
Huanhuan Xie
SWShan Wang
Shan Wang
SYSiyu Yang
Siyu Yang
LHLing Hu
Ling Hu
In the era of artificial intelligence (AI), a great deal of attention is being paid to AI in radiological practice. There are a large number of AI products on the radiological market based on X-rays, computed tomography, magnetic resonance imaging, and ultrasound. AI will not only change the way of radiological practice but also the way of radiological education. It is still not clearly defined about the exact role AI will play in radiological practice, but it will certainly be consolidated into radiological education in the foreseeable future. However, there are few literatures that have comprehensively summarized the attitudes, opportunities and challenges that AI can pose in the different training phases of radiologists, from university education to continuing education. Herein, we describe medical students’ attitudes towards AI, summarize the role of AI in radiological education, and analyze the challenges that AI can pose in radiological education.

1 January 2020 in NeuroImage: Clinical
Verified
Journal Article
Open access
CWChao Wang
Chao Wang
SWShuyue Wang
Shuyue Wang
ZSZhujing Shen
Zhujing Shen
WQWei Qian
Wei Qian
YJYeerfan Jiaerken
Yeerfan Jiaerken
MZMinming Zhang
Minming Zhang
• Smokers showed increased thalamic volume relative to nonsmokers. • Relapsers showed increased thalamic volume relative to nonrelapsers. • Relapsers showed decreased thalamo-precuneus rsFC relative to nonrelapsers. • Thalamic volume and rsFC achieved predictive accuracy of 75.7% for smoking relapse.

21 May 2020 in Addiction Biology
Verified
Journal Article
Closed access
PDF file
CWChao Wang
Chao Wang
PHPeiyu Huang
Peiyu Huang
ZSZhujing Shen
Zhujing Shen
WQWei Qian
Wei Qian
SWShuyue Wang
Shuyue Wang
MZMinming Zhang
Minming Zhang